Psych-STRATA’s presence at the EPA Congress provided an important opportunity to showcase the project’s work on advancing stratified pharmacogenomics in severe mental illness, as well as to contribute to broader discussions on personalised approaches to mental health care.
Beyond dissemination, the event also served as a valuable moment for collaboration. With partners attending from across Europe, the EPA Congress created a space to reconnect in person, strengthen relationships, and align on the next phases of the project. These face-to-face exchanges remain essential for maintaining strong partnerships and ensuring coordinated progress across work areas.
Participating in EPA 2026 also reinforced Psych-STRATA’s commitment to engaging with the wider mental health community, sharing insights, and promoting research that supports more effective, personalised treatment approaches.
As the project continues, moments like these play a key role in building momentum, fostering collaboration, and ensuring that research translates into real-world impact for people living with severe mental illness.
